- $10.71bn
- $11.53bn
- $2.96bn
- 86
- 18
- 87
- 68
Annual cashflow statement for Bruker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 198 | 161 | 281 | 299 | 429 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 19.7 | 43.3 | 44.1 | 46 | -81.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -74.5 | 69.6 | -126 | -144 | -87.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 213 | 332 | 282 | 274 | 350 |
| Capital Expenditures | -73 | -97.2 | -92 | -129 | -107 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -85.4 | -95.5 | -100 | -122 | -219 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -158 | -193 | -192 | -252 | -326 |
| Financing Cash Flow Items | -10.6 | -8.8 | -0.5 | -14.5 | 0.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 300 | -162 | 319 | -415 | -193 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 356 | 3.6 | 386 | -423 | -157 |